The unified cardiometabolic disease continuum: mechanistic stages of a single pathophysiological process

BackgroundType 2 diabetes mellitus (T2DM), atherosclerotic cardiovascular disease (ASCVD), heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD), hypertension, and chronic kidney disease (CKD) share risk factors and may represent end...

Descripció completa

Dades bibliogràfiques

Autors principals:	Luz María Quirino-Vela, Miguel A. Mayoral-Chávez, Carlos A. Matías-Cervantes, Yobana Pérez-Cervera, Iván A. García-Montalvo, Juan Alpuche
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-07-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	cardiometabolic continuum cardiometabolic risk ceramides epicardial adipose tissue gut microbiome NLRP3 inflammasome
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2026.1897556/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!